- Report
- October 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- July 2021
- 50 Pages
China
From €2498EUR$2,600USD£2,148GBP
- Report
- February 2024
- 101 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$3,902USD£3,115GBP
- Report
- May 2024
- 50 Pages
Global
From €2546EUR$2,650USD£2,189GBP
- Report
- November 2023
- 215 Pages
China
From €3843EUR$4,000USD£3,305GBP
- Report
- November 2023
- 109 Pages
China
From €1730EUR$1,800USD£1,487GBP
Nifedipine is a calcium channel blocker used to treat high blood pressure and angina. It is a commonly prescribed cardiovascular drug, and is available in both immediate-release and extended-release formulations. Nifedipine is also used to treat preterm labor, Raynaud's phenomenon, and hypertrophic cardiomyopathy. It is generally well-tolerated, but can cause side effects such as headache, dizziness, and swelling.
Nifedipine is available in both generic and brand-name formulations. Brand-name formulations include Procardia, Adalat, and Nifediac. Generic formulations are available from a variety of manufacturers.
In the Nifedipine market, some of the major players include Pfizer, Bayer, Teva Pharmaceuticals, Mylan, and Sandoz. Show Less Read more